ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1060

B-cell-rich Inflammatory Myopathies in Adults: Striking Association with Connective Tissue Diseases

Pat Korathanakhun1, Océane Landon-Cardinal2, Valérie Leclair3, Benjamin Ellezam4, Alain Meyer5, Josiane Bourré-Tessier2, Anne-Marie Mansour6, Sandrine Larue7, François Grand'Maison7, Rami Massie8, Matthieu Le Page9, Catherine Isabelle7, Nathalie Routhier6, Flavie Roy10, Minoru Satoh11, Marvin Fritzler12, Jean-Luc Senécal2, Yves Troyanov13, Marie Hudson3, Jason Karamchandani14 and Erin O'Ferrall8, 1Montreal Neurological Institute and Hospital, Montreal, QC, Canada, 2Division of Rheumatology, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada, 3Division of Rheumatology, Jewish General Hospital, Montréal, QC, Canada, 4Division of Pathology, Centre hospitalier universitaire Sainte-Justine, Montréal, QC, Canada, 5Service de rhumatologie et Centre de références des maladies autoimmunes rares, Hôpitaux universitaires de Strasbourg, Strasbourg, France, 6Hôpital du Sacré-Coeur de Montréal, Montreal, QC, Canada, 7Hôpital Charles-Lemoyne, Longueuil, QC, Canada, 8Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, Montreal, QC, Canada, 9Centre hospitalier de Lanaudière, Saint-Charles-Borromée, QC, Canada, 10Uiversité de Montréal, Montreal, QC, Canada, 11Department of Clinical Nursing, University of Occupational and Environmental Health, Kitakyushu, Japan, 12Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 13Division of Rheumatology, Hôpital du Sacré-Coeur, Montréal, QC, Canada, 14Department of Pathology, Montreal Neurological Institute and Hospital, Montreal, QC, Canada

Meeting: ACR Convergence 2020

Keywords: B-Lymphocyte, Myopathies, Myositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Muscle Biology, Myositis & Myopathies Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Myositis with significant B-cell infiltrates on muscle biopsy has scarcely been described in adults. Radke (2018) found B cells in adult dermatomyositis (DM) and stratified them as classic, B-cell-rich and follicle-like DM. In patients without DM, three neuropathology studies described myositis with significant B-cell infiltrates. De Bleeker (1996) reported 7 patients with biopsies showing nodules resembling lymph nodes, i.e. a B-cell-rich center surrounded by CD4+ T-cell-rich peripheral zone; notable findings were cervical muscle weakness and the presence of a connective tissue disease (CTD). Pestronk (2006) described 9 patients with prominent perimysial and perivascular B-cell infiltrates, cervical muscle weakness and either myasthenia gravis or a CTD. Espitia-Thibault (2017) studied 4 patients with primary Sjögren syndrome (SS) and myositis; and found germinal centre-like structures composed predominantly of CD4+ T cells and B cells. The aim of the present study was to describe the clinicoserological findings of patients with B-cell-rich infiltrates on muscle biopsy, and no DM.

Methods: Muscle biopsies with significant B-cell infiltrates (≥ 30 CD20+ cells/aggregate) were identified from 2 neuropathology centers. All cases were reviewed in multidisciplinary meetings. Clinical, serological, pathological features and classification criteria for inclusion body myositis (IBM) were recorded. Patterns of muscle involvement were noted, including cervical, finger flexor and quadriceps weakness. The presence of a CTD and cancer within 3 years of myositis diagnosis was also recorded. Patients with a DM rash were excluded.

Results: Ten patients with myositis, no DM rash, and significant B-cell infiltrates on muscle biopsy were included. Nine were female; median age at myositis diagnosis was 66.5 years (range 51-85). Median CK level was 291 UI/L (range 98–4372). Two patients with normal strength, but myalgias (n=1) or cervical muscle edema (n=1), had imaging suggestive of myositis. All remaining patients had cervical muscle weakness (n=8), and 3 had objective oropharyngeal dysphagia. Quadriceps (n=6) and finger flexor (n=3) weakness was noted, and 4 patients met the Lloyd IBM classification criteria. Associated diseases included anti-CCP positive RA (n=3), systemic sclerosis (SSc) (n=3), primary SS (n=1), systemic lupus erythematosus (n=1) and lung cancer (n=1). Serologically, all patients but one were tested: none had myositis-specific autoantibodies (aAbs) and 2 patients with SSc had anti-Th/To (n=1) and anti-PM-Scl (n=1) aAbs. Anti-Ro52/TRIM21 (n=4), anti-SSA/Ro60(n=3), anti-SSB/La (n=2) were present. Anti-NT5c1A aAbs were present in 1 of 3 tested patients.

Conclusion: Myositis and significant B-cell infiltrates were associated, as in previous studies, with various CTDs, and not only with SS. Cervical weakness and features of IBM were frequent in this subset of patients. CD20 stains were listed as optional in the 205th European Neuromuscular Centre international workshop. Routine CD20 staining should be considered in patients with cervical muscle weakness and suspected myositis in the setting of an associated CTD.


Disclosure: P. Korathanakhun, None; O. Landon-Cardinal, None; V. Leclair, None; B. Ellezam, None; A. Meyer, None; J. Bourré-Tessier, None; A. Mansour, None; S. Larue, None; F. Grand'Maison, None; R. Massie, None; M. Le Page, None; C. Isabelle, None; N. Routhier, None; F. Roy, None; M. Satoh, None; M. Fritzler, Inova Diagnostics Inc, 5, 8, Werfen International, 5, 8; J. Senécal, None; Y. Troyanov, None; M. Hudson, None; J. Karamchandani, None; E. O'Ferrall, Sanofi Genzyme, 2, Acceleron, 2, Biogen, 8.

To cite this abstract in AMA style:

Korathanakhun P, Landon-Cardinal O, Leclair V, Ellezam B, Meyer A, Bourré-Tessier J, Mansour A, Larue S, Grand'Maison F, Massie R, Le Page M, Isabelle C, Routhier N, Roy F, Satoh M, Fritzler M, Senécal J, Troyanov Y, Hudson M, Karamchandani J, O'Ferrall E. B-cell-rich Inflammatory Myopathies in Adults: Striking Association with Connective Tissue Diseases [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/b-cell-rich-inflammatory-myopathies-in-adults-striking-association-with-connective-tissue-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/b-cell-rich-inflammatory-myopathies-in-adults-striking-association-with-connective-tissue-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology